Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Protalix BioTherapeutics Inc. (DE).
Protalix BioTherapeutics Inc. (DE) business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Protalix BioTherapeutics Inc. (DE) are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Protalix BioTherapeutics Inc. (DE) , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Protalix BioTherapeutics Inc. (DE) including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Protalix BioTherapeutics Inc. (DE) and all latest updates of the company are provided.
The 2025 version of Protalix BioTherapeutics Inc. (DE) report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Protalix BioTherapeutics Inc. (DE)- Key Facts
2.2 Protalix BioTherapeutics Inc. (DE)- Geographic Locations
2.3 Protalix BioTherapeutics Inc. (DE)- Subsidiaries and Affiliates
2.4 Protalix BioTherapeutics Inc. (DE)- Business Divisions
2.5 Protalix BioTherapeutics Inc. (DE)- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Protalix BioTherapeutics Inc. (DE) Strategic Analysis Review
3.1 Protalix BioTherapeutics Inc. (DE)- Key Strategies
3.2 Protalix BioTherapeutics Inc. (DE)- Company Outlook Statement
3.3 Protalix BioTherapeutics Inc. (DE)- SWOT Analysis
3.3.1 Protalix BioTherapeutics Inc. (DE)- Key Strengths
3.3.2 Protalix BioTherapeutics Inc. (DE)- Key Weaknesses
3.3.3 Protalix BioTherapeutics Inc. (DE)- Potential Opportunities
3.3.4 Protalix BioTherapeutics Inc. (DE)- Potential Threats
3.4 Protalix BioTherapeutics Inc. (DE)- Key Competitors
4. Business Description of the Company
4.1 Protalix BioTherapeutics Inc. (DE)- Business Overview
4.2 Protalix BioTherapeutics Inc. (DE)- Operations by Segment
5 Products and Services Details
5.1 Protalix BioTherapeutics Inc. (DE)- Key Products
5.2 Protalix BioTherapeutics Inc. (DE)- Key Service Areas
5.3 Protalix BioTherapeutics Inc. (DE)- Key Brands
6 Company Developments
6.1 Protalix BioTherapeutics Inc. (DE)- Company History
6.2 Protalix BioTherapeutics Inc. (DE)- Latest Developments
7 Financial Analysis
7.1 Protalix BioTherapeutics Inc. (DE)- Income Statements
7.2 Protalix BioTherapeutics Inc. (DE)- Balance Sheet
7.3 Protalix BioTherapeutics Inc. (DE)- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Protalix BioTherapeutics Inc. (DE)- Direct Competitors
8.2 Protalix BioTherapeutics Inc. (DE)- Competitor Financial Ratios comparison
8.3 Protalix BioTherapeutics Inc. (DE)- Competitor Stock Charts Comparison
8.4 Protalix BioTherapeutics Inc. (DE)- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
